David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Terreno Realty
TRNO
$7.51B
| $603K | ﹤0.01% |
16,642
+9,387
| +129% | +$329K |
|
|
IBTX
2777
CALL
DELISTED
Independent Bank Group, Inc.
IBTX
| $603K | ﹤0.01% |
10,000
-10,000
| -50% | -$582K |
|
2778
PUT
Paychex
PAYX
$44.8B
| $600K | ﹤0.01% |
10,000
| – | – |
|
2779
PUT
Genesco
GCO
$390M
| $599K | ﹤0.01% |
+22,500
| New | +$636K |
|
2780
PUT
Medtronic
MDT
$119B
| $599K | ﹤0.01% |
7,700
+900
| +13% | +$74.7K |
|
|
MODV
2781
DELISTED
ModivCare
MODV
| $597K | ﹤0.01% |
11,034
-4,064
| -27% | -$208K |
|
|
REN
2782
CALL
DELISTED
Resolute Energy Corporaton
REN
| $594K | ﹤0.01% |
20,000
-10,800
| -35% | -$321K |
|
2783
CALL
Kinder Morgan
KMI
$69B
| $591K | ﹤0.01% |
+30,800
| New | +$600K |
|
2784
Banco de Chile
BCH
$21.7B
| $590K | ﹤0.01% |
19,838
-8,491
| -30% | -$239K |
|
|
SYNT
2785
CALL
DELISTED
Syntel Inc
SYNT
| $590K | ﹤0.01% |
30,000
| – | – |
|
2786
American Homes 4 Rent
AMH
$12.5B
| $589K | ﹤0.01% |
+27,134
| New | +$609K |
|
|
ECYT
2787
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $588K | ﹤0.01% |
417,141
+194,182
| +87% | +$271K |
|
|
MZTI
2788
The Marzetti Company
MZTI
$3.17B
| $585K | ﹤0.01% |
4,866
-7,863
| -62% | -$949K |
|
2789
FirstCash
FCFS
$10.3B
| $584K | ﹤0.01% |
9,255
+3,375
| +57% | +$199K |
|
2790
Harmonic Inc
HLIT
$1.31B
| $583K | ﹤0.01% |
191,294
+83,636
| +78% | +$311K |
|
2791
Intrepid Potash
IPI
$510M
| $582K | ﹤0.01% |
13,348
-30,430
| -70% | -$1.03M |
|
2792
PUT
Group 1 Automotive
GPI
$3.09B
| $580K | ﹤0.01% |
8,000
-3,100
| -28% | -$191K |
|
|
PRO
2793
DELISTED
PROS Holdings
PRO
| $578K | ﹤0.01% |
23,942
-20,588
| -46% | -$548K |
|
|
LL
2794
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
| $577K | ﹤0.01% |
14,800
| – | – |
|
2795
Community Bank
CBU
$3.32B
| $575K | ﹤0.01% |
10,415
-11,811
| -53% | -$631K |
|
|
VEDL
2796
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $575K | ﹤0.01% |
29,711
-90,200
| -75% | -$1.66M |
|
2797
NRG Energy
NRG
$23.5B
| $572K | ﹤0.01% |
22,337
-216,164
| -91% | -$5.11M |
|
2798
Onto Innovation
ONTO
$17.3B
| $572K | ﹤0.01% |
19,865
+10,298
| +108% | +$271K |
|
2799
PUT
Synaptics
SYNA
$3.66B
| $572K | ﹤0.01% |
+14,600
| New | +$658K |
|
2800
CALL
Lear
LEA
$8.18B
| $571K | ﹤0.01% |
+3,300
| New | +$499K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.